Cite
583 - Bacteremia While Receiving Chemotherapy Prior to Stem Cell Infusion is Uncommon Despite Frequent Use of Empiric Antibiotics: Results of a Multi-Institutional Analysis.
MLA
Craddock, John A., et al. “583 - Bacteremia While Receiving Chemotherapy Prior to Stem Cell Infusion Is Uncommon Despite Frequent Use of Empiric Antibiotics: Results of a Multi-Institutional Analysis.” Biology of Blood & Marrow Transplantation, vol. 24, Mar. 2018, p. S424. EBSCOhost, https://doi.org/10.1016/j.bbmt.2017.12.506.
APA
Craddock, J. A., Tewari, P., Hilden, J. M., Leung, K. S., Haslam, D., Lane, A., Thikkurissy, S., El-Bietar, J., Alonso, P. B., Davies, S. M., & Dandoy, C. E. (2018). 583 - Bacteremia While Receiving Chemotherapy Prior to Stem Cell Infusion is Uncommon Despite Frequent Use of Empiric Antibiotics: Results of a Multi-Institutional Analysis. Biology of Blood & Marrow Transplantation, 24, S424. https://doi.org/10.1016/j.bbmt.2017.12.506
Chicago
Craddock, John A., Priti Tewari, Joanne M. Hilden, Kathryn S. Leung, David Haslam, Adam Lane, Sarat Thikkurissy, et al. 2018. “583 - Bacteremia While Receiving Chemotherapy Prior to Stem Cell Infusion Is Uncommon Despite Frequent Use of Empiric Antibiotics: Results of a Multi-Institutional Analysis.” Biology of Blood & Marrow Transplantation 24 (March): S424. doi:10.1016/j.bbmt.2017.12.506.